554 related articles for article (PubMed ID: 25870164)
1. High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes.
Vallejo F; Barrio G; Brugal MT; Pulido J; Toro C; Sordo L; Espelt A; Bravo MJ;
J Epidemiol Community Health; 2015 Jun; 69(6):599-603. PubMed ID: 25870164
[TBL] [Abstract][Full Text] [Related]
2. HCV seroconversion among never-injecting heroin users at baseline: no predictors identified other than starting injection.
Bravo MJ; Vallejo F; Barrio G; Brugal MT; Molist G; Pulido J; Sordo L; de la Fuente L;
Int J Drug Policy; 2012 Sep; 23(5):415-9. PubMed ID: 22421554
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
[TBL] [Abstract][Full Text] [Related]
4. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
Allen EJ; Palmateer NE; Hutchinson SJ; Cameron S; Goldberg DJ; Taylor A
Int J Drug Policy; 2012 Sep; 23(5):346-52. PubMed ID: 22940142
[TBL] [Abstract][Full Text] [Related]
5. Use of supervised injection facilities and injection risk behaviours among young drug injectors.
Bravo MJ; Royuela L; De la Fuente L; Brugal MT; Barrio G; Domingo-Salvany A;
Addiction; 2009 Apr; 104(4):614-9. PubMed ID: 19215603
[TBL] [Abstract][Full Text] [Related]
6. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
Ruan Y; Qin G; Yin L; Chen K; Qian HZ; Hao C; Liang S; Zhu J; Xing H; Hong K; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S39-46. PubMed ID: 18172390
[TBL] [Abstract][Full Text] [Related]
7. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention.
Artenie AA; Roy É; Zang G; Jutras-Aswad D; Bamvita JM; Puzhko S; Daniel M; Bruneau J
Int J Drug Policy; 2015 Oct; 26(10):970-5. PubMed ID: 26005038
[TBL] [Abstract][Full Text] [Related]
9. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China.
Garten RJ; Lai S; Zhang J; Liu W; Chen J; Vlahov D; Yu XF
Int J Epidemiol; 2004 Feb; 33(1):182-8. PubMed ID: 15075167
[TBL] [Abstract][Full Text] [Related]
10. Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada.
Jacka B; Roy É; Høj S; Minoyan N; Artenie AA; Zang G; Jutras-Aswad D; Bruneau J
J Viral Hepat; 2019 Dec; 26(12):1413-1422. PubMed ID: 31433888
[TBL] [Abstract][Full Text] [Related]
11. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
[TBL] [Abstract][Full Text] [Related]
12. High Prevalence and Incidence of HIV and HCV Among New Injecting Drug Users With a Large Proportion of Migrants--Is Prevention Failing?
Folch C; Casabona J; Espelt A; Majó X; Meroño M; Gonzalez V; Wiessing L; Colom J; Brugal MT;
Subst Use Misuse; 2016 Jan; 51(2):250-60. PubMed ID: 26820260
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco.
Hahn JA; Page-Shafer K; Lum PJ; Ochoa K; Moss AR
Hepatology; 2001 Jul; 34(1):180-7. PubMed ID: 11431749
[TBL] [Abstract][Full Text] [Related]
14. The investigation of HIV and HCV infection and risk factors among opiate drug users in Beijing, China.
Bao YP; Du C; Lu HY; Lian Z; Qiu Y; Mu Y; Yan SY; Liu ZM
Am J Drug Alcohol Abuse; 2012 Mar; 38(2):140-5. PubMed ID: 22175771
[TBL] [Abstract][Full Text] [Related]
15. Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users.
van den Berg CH; Smit C; Bakker M; Geskus RB; Berkhout B; Jurriaans S; Coutinho RA; Wolthers KC; Prins M
Eur J Epidemiol; 2007; 22(3):183-93. PubMed ID: 17334821
[TBL] [Abstract][Full Text] [Related]
16. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
17. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.
Turner KM; Hutchinson S; Vickerman P; Hope V; Craine N; Palmateer N; May M; Taylor A; De Angelis D; Cameron S; Parry J; Lyons M; Goldberg D; Allen E; Hickman M
Addiction; 2011 Nov; 106(11):1978-88. PubMed ID: 21615585
[TBL] [Abstract][Full Text] [Related]
18. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users.
Miller CL; Johnston C; Spittal PM; Li K; Laliberté N; Montaner JS; Schechter MT
Hepatology; 2002 Sep; 36(3):737-42. PubMed ID: 12198668
[TBL] [Abstract][Full Text] [Related]
19. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
20. The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users.
Bruneau J; Roy E; Arruda N; Zang G; Jutras-Aswad D
Addiction; 2012 Jul; 107(7):1318-27. PubMed ID: 22248184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]